Compare Summit Therapeutics Inc (SMMT) vs Simon Property Group Inc (SPG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Summit Therapeutics Inc vs Simon Property Group Inc — how do they compare? Summit Therapeutics Inc trades at $14.57 (market cap $10.48B), while Simon Property Group Inc trades at $227 (market cap $74.00B). The key difference: Simon Property Group Inc is far larger — about 7.1× Summit Therapeutics Inc's market cap, and Simon Property Group Inc pays a 3.86% dividend while Summit Therapeutics Inc pays none. Which is the better fit depends on your goals.
| SMMT | SPG | |
|---|---|---|
Market Cap | $10.48B | $74.00B |
Sector | Health | Real Estate |
52-Week High | $29.32 | $228.70 |
52-Week Low | $13.05 | $160.68 |
Enterprise Value | $9.90B | $102.48B |
Dividend Yield | — | 3.86% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Summit Therapeutics Inc
Summit Therapeutics Inc. is a biopharmaceutical company focused on the development and commercialization of new medicines for the treatment of infectious diseases and other unmet medical needs. The company's lead product candidate is an antibiotic for the treatment of Clostridioides difficile infection (CDI), a serious infection of the colon. Summit Therapeutics is committed to bringing innovative therapies to market to address global health challenges and improve patient outcomes.
Read more on SMMT →About Simon Property Group Inc
Simon Property Group is the second- largest real estate investment trust in the United States. Its portfolio includes an interest in 207 properties: 119 traditional malls, 69 premium outlets, 14 Mills centers (a combination of a traditional mall, outlet center, and big-box retailers), six lifestyle centers, and five other retail properties. Simon's portfolio averaged $693 in sales per square foot over the 12 months prior to the pandemic. The company also owns a 21% interest in Klepierre, a European retail company with investments in shopping centers in 16 countries, and joint venture interests in 33 premium outlets across 11 countries.
Read more on SPG →
